Reading Scientific Services Ltd (RSSL) has launched a dedicated pharmaceutical consultancy offering aimed at helping pharmaceutical, biopharmaceutical, and advanced therapy companies address increasingly complex challenges spanning quality, regulation, technical operations, and commercialization. This initiative is a strategic response to the evolving landscape of the pharmaceutical industry, where organizations are grappling with heightened expectations around data integrity, compliance with new Annex 1 requirements, and the intricacies of global supply chains.
The consultancy service distinguishes itself by leveraging RSSL’s extensive scientific and technical infrastructure, enabling clients to access laboratory capabilities, analytical testing, and R&D expertise. This integrated approach is designed to provide immediate support for urgent technical and compliance issues while fostering long-term organizational resilience through training and knowledge transfer. Emily Ness, Head of Pharmaceutical Training & Consultancy at RSSL, emphasizes the goal of equipping clients with the confidence and capabilities to navigate future challenges independently.
By addressing both immediate needs and promoting sustainable capabilities, RSSL’s consultancy service positions itself as a vital resource for companies striving to excel in a rapidly changing regulatory environment and complex drug development landscape.
Get started today with Solo access →
